Skip to main content
Clinical Trials/CTRI/2024/12/077901
CTRI/2024/12/077901
Not yet recruiting
Phase 2

A comparative clinical study to evaluate the tranquilizing effect of yastimadhu ksheera paka and kushmanda rasayana granules in artists with social phobia.

Not provided1 site in 1 country30 target enrollmentStarted: December 31, 2024Last updated:

Overview

Phase
Phase 2
Status
Not yet recruiting
Enrollment
30
Locations
1
Primary Endpoint
Assessment will be done by scoring subjective parameters by assessing on 0th, 14th and 28th day.

Overview

Brief Summary

This is Raandomised open labelled parallel group study comparing the safety and efficacy of the trial drug Group A – Yastimadhu Ksheera Paka1pala before food morning Group B – Kushmanda Rasayana Granules12grams with milk on empty stomach early morning for 28 days in each group and study will be conducted in Shri Dharmasthala Manjunatheshwara college of Ayurveda Kuthpady Udupi, Karnataka, India. The primary measures will be assessed through Severity Measure for Social Anxiety Disorder (Social Phobia). According to American psychiatric association, Hamilton’s Anxiety Rating Scale, Manasika bhava scale. The secondary outcome majors will be assessed based on the WHO Quality of life Scale-Brief hence the study is an effort to prove the efficacy of Yastimadhu Ksheera Paka and Kushmanda Rasayana Granules in artists with social phobia.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 30.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1.Subject fulfilling the DSM-5 Diagnostic criteria [for Social Phobia].
  • 2.Artists – stage performers (Dancers, Singers, musician, debate, pick and speak, pick and act) 3.Age group: 18 -30yrs 4.Participants who are willing and able to provide informed consent.

Exclusion Criteria

  • Subjects suffering from any other psychiatric and any organic disorders, lactating and pregnant Women will be excluded.

Outcomes

Primary Outcomes

Assessment will be done by scoring subjective parameters by assessing on 0th, 14th and 28th day.

Time Frame: Observation will be done on 0th , 14th and 28th day

Severity Measure for Social Anxiety Disorder (Social Phobia). According to American psychiatric association.

Time Frame: Observation will be done on 0th , 14th and 28th day

Hamilton’s Anxiety Rating Scale.

Time Frame: Observation will be done on 0th , 14th and 28th day

WHO Quality of life Scale-Brief.

Time Frame: Observation will be done on 0th , 14th and 28th day

Manasika bhava scale

Time Frame: Observation will be done on 0th , 14th and 28th day

Scored parameters will be analysed statistically after the treatment. All the subjective parameters and scales will be assessed using Wilcoxon signed rank test within the groups and Mann-Whitney U test in between the groups.

Time Frame: Observation will be done on 0th , 14th and 28th day

Secondary Outcomes

  • quality of life(0th and 28th day)

Investigators

Sponsor
Not provided
Responsible Party
Principal Investigator
Principal Investigator

Dr Shantala S Bharbhari

Shri Dharmashtala Manjunateshwara College of Ayurveda,Hospital and Research Centre, kuthpady Udupi

Study Sites (1)

Loading locations...

Similar Trials